Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

Go back to Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Misses Q1 EPS by 13c

May 7, 2019 5:01 PM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q1 EPS of ($1.32), $0.13 worse than the analyst estimate of ($1.19). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $16.21 million.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

... More